Kayra Patent · ISO 13485
ISO 13485 Certificate Medical Devices Quality Management System
ISO 13485 is a medical-device quality management system standard for regulatory purposes. It addresses the organisation’s actual device-lifecycle role. A system certificate is not CE marking, device market authorisation or an exemption from regulatory inspection. The applicant implements its system and prepares procedures specific to its own operations and operating records. A certification enquiry to Kayra is limited to actual activities and sites, application information, authority and impartiality review; it does not include designing or implementing the client’s management system. The certification body, other parts of the same legal entity and entities under its organisational control cannot offer or provide management-system consultancy; separate contracts do not remove this restriction.
Define role, devices and regulatory responsibilities
Specify whether the organisation designs, manufactures, supplies components, installs or services devices. Identify device families, sites, outsourced work and relevant market requirements. Do not assume a supplier carries every obligation of the finished-device manufacturer. Explain design responsibility and any permitted applicability limits against the standard and actual role. The application scope must describe the activities assessed, not suggest approval of every device sold.
Trace a device record through its controls
Connect product requirements, risk-related decisions, supplier controls, production records, acceptance and traceability. In a hypothetical component substitution, check whether the new material affects an approved design, process or regulatory file before release. Where process results cannot be fully verified afterwards, examine the applicable validation needs. A finished-product inspection does not automatically replace that evidence, and the test programme for an unknown device is not invented here.
Review complaints, changes and market boundaries
Link complaint assessment to the device or batch, investigation, corrective action and any applicable regulatory reporting. Retain competence, internal audit and management-review evidence. In the USA, FDA’s QMSR took effect on 2 February 2026 and incorporates ISO 13485:2016; an ISO certificate does not replace FDA requirements or inspection. EU MDR/IVDR and CE routes are separate. Device families, special processes, sites and outsourced work affect audit planning and the quotation.
Application, independent decision and quotation
Supply the legal entity, actual activities, locations, workforce, shifts, supplier dependencies and existing records. Verify the proposed programme, edition and the certification body’s current scope. Initial audit stages, findings and corrective-action evidence precede a separate impartial decision; ISO does not issue certificates. Distinguish implementation and any testing costs from independent assessment, surveillance, recertification, travel and follow-up. Missing records or unresolved actions affect the calendar; neither a paid application nor an audit report guarantees certification.
Official sources and application limits
The operating examples are hypothetical, not customer events or guaranteed decisions. The actual standard and competent body determine requirements.
TRTürkçe
ENEnglish
AZAzərbaycanca
UZO‘zbekcha
ARالعربية
FRFrançais
DEDeutsch
RUРусский